(Q45083281)

English

Serum vancomycin levels resulting from continuous or intermittent infusion in critically ill burn patients with or without continuous renal replacement therapy

scientific article published in November 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Serum vancomycin levels resulting from continuous or intermittent infusion in critically ill burn patients with or without continuous renal replacement therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

1 reference

based on heuristic

inferred from title

author name string

Kevin S Akers

1

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Jason M Cota

2

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Kevin K Chung

3

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Evan M Renz

4

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Katrin Mende

5

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Clinton K Murray

6

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 November 2012

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Journal of Burn Care and Research

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

33

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

e254-62

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Altered vancomycin dose vs. serum concentration relationship in burn patients.

1 reference

https://api.crossref.org/works/10.1097%2FBCR.0B013E31825042FA

21 January 2018

Vancomycin pharmacokinetics in burn patients and intravenous drug abusers

1 reference

https://api.crossref.org/works/10.1097%2FBCR.0B013E31825042FA

21 January 2018

Influence of burns on pharmacokinetics and pharmacodynamics of drugs used in the care of burn patients

1 reference

https://api.crossref.org/works/10.1097%2FBCR.0B013E31825042FA

21 January 2018

Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists

1 reference

https://api.crossref.org/works/10.1097%2FBCR.0B013E31825042FA

21 January 2018

Continuous versus intermittent infusion of vancomycin in severe Staphylococcal infections: prospective multicenter randomized study

1 reference

https://api.crossref.org/works/10.1097%2FBCR.0B013E31825042FA

21 January 2018

Twenty-five year epidemiology of invasive methicillin-resistant Staphylococcus aureus (MRSA) isolates recovered at a burn center.

1 reference

https://api.crossref.org/works/10.1097%2FBCR.0B013E31825042FA

21 January 2018

Acute kidney injury, mortality, length of stay, and costs in hospitalized patients

1 reference

https://api.crossref.org/works/10.1097%2FBCR.0B013E31825042FA

21 January 2018

Systematic review: agranulocytosis induced by nonchemotherapy drugs

1 reference

https://api.crossref.org/works/10.1097%2FBCR.0B013E31825042FA

21 January 2018

Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children

1 reference

https://api.crossref.org/works/10.1097%2FBCR.0B013E31825042FA

21 January 2018

Risk factors for nephrotoxicity associated with continuous vancomycin infusion in outpatient parenteral antibiotic therapy

1 reference

https://api.crossref.org/works/10.1097%2FBCR.0B013E31825042FA

21 January 2018

Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections

1 reference

https://api.crossref.org/works/10.1097%2FBCR.0B013E31825042FA

21 January 2018

Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity

1 reference

https://api.crossref.org/works/10.1097%2FBCR.0B013E31825042FA

21 January 2018

Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients

1 reference

https://api.crossref.org/works/10.1097%2FBCR.0B013E31825042FA

21 January 2018

Intensity of renal support in critically ill patients with acute kidney injury

1 reference

https://api.crossref.org/works/10.1097%2FBCR.0B013E31825042FA

21 January 2018

Continuous-infusion beta-lactam antibiotics during continuous venovenous hemofiltration for the treatment of resistant gram-negative bacteria

1 reference

https://api.crossref.org/works/10.1097%2FBCR.0B013E31825042FA

21 January 2018

Identifiers

10.1097/BCR.0B013E31825042FA

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45083281&oldid=2065361338"